The Revolution of Myelodysplastic Syndromes

Por Sekeres, Mikkael A., Bejanyan, Nelli
Publicado em 2011

On the Edge of Life, I: Assessment of, Reaction to, and Management of the Terminally Ill Recorded in an Intensive Care Unit Journal

Por Sekeres, Mikkael A., Stern, Theodore A.
Publicado em 2002

On the Edge of Life, II: House Officer Struggles Recorded in an Intensive Care Unit Journal

Por Sekeres, Mikkael A., Stern, Theodore A.
Publicado em 2002

Targeted treatment of acute myeloid leukemia in older adults: role of gemtuzumab ozogamicin

Por Duong, Hien K, Sekeres, Mikkael A
Publicado em 2009

Defining prior therapy in myelodysplastic syndromes and criteria for relapsed and refractory disease: implications for clinical trial design and enrollment

Por Sekeres, Mikkael A., Steensma, David P.
Publicado em 2009

The Challenging World of Cytopenias: Distinguishing Myelodysplastic Syndromes From Other Disorders of Marrow Failure

Por DeZern, Amy E., Sekeres, Mikkael A.
Publicado em 2014

Molecular Testing in Myelodysplastic Syndromes for the Practicing Oncologist: Will the Progress Fulfill the Promise?

Por Nazha, Aziz, Sekeres, Mikkael A., Gore, Steven D., Zeidan, Amer M.
Publicado no Oncologist (2015)

The need for additional genetic markers for MDS stratification: what does the future hold for prognostication?

Por Otrock, Zaher K., Tiu, Ramon V., Maciejewski, Jaroslaw P., Sekeres, Mikkael A.
Publicado no Expert Rev Hematol (2013)

Phase 2, single-arm trial to evaluate the effectiveness of darbepoetin alfa for correcting anaemia in patients with myelodysplastic syndromes

Por Gabrilove, Janice, Paquette, Ronald, Lyons, Roger M, Mushtaq, Chaudhry, Sekeres, Mikkael A, Tomita, Dianne, Dreiling, Lyndah
Publicado em 2008

Patterns of missplicing due to somatic U2AF1 mutations in myeloid neoplasms

Por Przychodzen, Bartlomiej, Jerez, Andres, Guinta, Kathryn, Sekeres, Mikkael A., Padgett, Richard, Maciejewski, Jaroslaw P., Makishima, Hideki
Publicado em 2013

Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML

Por Gondek, Lukasz P., Tiu, Ramon, O'Keefe, Christine L., Sekeres, Mikkael A., Theil, Karl S., Maciejewski, Jaroslaw P.
Publicado em 2008

Characteristics of US Patients with Myelodysplastic Syndromes: Results of Six Cross-sectional Physician Surveys

Por Sekeres, Mikkael A., Schoonen, W. Marieke, Kantarjian, Hagop, List, Alan, Fryzek, Jon, Paquette, Ronald, Maciejewski, Jaroslaw P.
Publicado em 2008

Refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T), another myeloproliferative condition characterized by JAK2 V617F mutation

Por Szpurka, Hadrian, Tiu, Ramon, Murugesan, Gurunathan, Aboudola, Samer, Hsi, Eric D., Theil, Karl S., Sekeres, Mikkael A., Maciejewski, Jaroslaw P.
Publicado em 2006

Relationship of Treatment-Related Cytopenias and Response to Lenalidomide in Patients With Lower-Risk Myelodysplastic Syndromes

Por Sekeres, Mikkael A., Maciejewski, Jaroslaw P., Giagounidis, Aristotle A.N., Wride, Kenton, Knight, Robert, Raza, Azra, List, Alan F.
Publicado em 2008

Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes

Por Steensma, David P., Bejar, Rafael, Jaiswal, Siddhartha, Lindsley, R. Coleman, Sekeres, Mikkael A., Hasserjian, Robert P., Ebert, Benjamin L.
Publicado no Blood (2015)

Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients

Por Sekeres, Mikkael A., Elson, Paul, Kalaycio, Matt E., Advani, Anjali S., Copelan, Edward A., Faderl, Stefan, Kantarjian, Hagop M., Estey, Elihu
Publicado em 2009

Spectrum of mutations in RARS-T patients includes TET2 and ASXL1 mutations

Por Szpurka, Hadrian, Jankowska, Anna M., Makishima, Hideki, Bodo, Juraj, Bejanyan, Nelli, Hsi, Eric D., Sekeres, Mikkael A., Maciejewski, Jaroslaw P.
Publicado em 2010

Randomized, phase IIb study of low-dose cytarabine and lintuzumab versus low-dose cytarabine and placebo in older adults with untreated acute myeloid leukemia

Por Sekeres, Mikkael A., Lancet, Jeffrey E., Wood, Brent L., Grove, Laurie E., Sandalic, Larissa, Sievers, Eric L., Jurcic, Joseph G.
Publicado em 2013

The NEDD8-activating enzyme inhibitor MLN4924 disrupts nucleotide metabolism and augments the efficacy of cytarabine

Por Nawrocki, Steffan T., Kelly, Kevin R., Smith, Peter G., Keaton, Mignon, Carraway, Hetty, Sekeres, Mikkael A., Maciejewski, Jaroslaw P., Carew, Jennifer S.
Publicado no Clin Cancer Res (2014)

Aberrant DNA methylation is a dominant mechanism in MDS progression to AML

Por Jiang, Ying, Dunbar, Andrew, Gondek, Lukasz P., Mohan, Sanjay, Rataul, Manjot, O'Keefe, Christine, Sekeres, Mikkael, Saunthararajah, Yogen, Maciejewski, Jaroslaw P.
Publicado em 2009